Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.840
-0.220 (-10.68%)
Dec 5, 2025, 4:00 PM EST - Market closed
Artelo Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Aug '21 Aug 31, 2021 |
| Selling, General & Admin | 5.42 | 4.12 | 4.23 | 5.96 | 6.29 | 4.6 | |
| Research & Development | 7.01 | 5.99 | 5.7 | 4.32 | 5.83 | 2.84 | |
| Operating Expenses | 12.43 | 10.11 | 9.93 | 10.29 | 12.13 | 7.44 | |
| Operating Income | -12.43 | -10.11 | -9.93 | -10.29 | -12.13 | -7.44 | |
| Interest Expense | -0.18 | - | - | -0.01 | - | - | |
| Interest & Investment Income | 0.01 | - | - | 0 | 0 | 0 | |
| Other Non Operating Income (Expenses) | 0.08 | - | - | - | - | - | |
| EBT Excluding Unusual Items | -12.53 | -10.11 | -9.93 | -10.29 | -12.12 | -7.44 | |
| Gain (Loss) on Sale of Investments | 0.03 | 0.28 | 0.64 | 0.21 | 0.02 | 0 | |
| Pretax Income | -12.49 | -9.83 | -9.29 | -10.08 | -12.11 | -7.44 | |
| Net Income | -12.49 | -9.83 | -9.29 | -10.08 | -12.11 | -7.44 | |
| Net Income to Common | -12.49 | -9.83 | -9.29 | -10.08 | -12.11 | -7.44 | |
| Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 23.24% | 8.88% | 4.48% | 27.04% | 79.12% | 403.69% | |
| EPS (Basic) | -18.96 | -18.29 | -18.83 | -21.35 | -32.57 | -35.84 | |
| EPS (Diluted) | -18.96 | -18.29 | -18.83 | -21.35 | -32.58 | -35.84 | |
| Free Cash Flow | -8.18 | -8.35 | -8.21 | -8.01 | -8 | -6.14 | |
| Free Cash Flow Per Share | -12.41 | -15.54 | -16.64 | -16.96 | -21.53 | -29.59 | |
| EBITDA | - | - | - | - | - | -7.44 | |
| D&A For EBITDA | - | - | - | - | - | 0 | |
| EBIT | -12.43 | -10.11 | -9.93 | -10.29 | -12.13 | -7.44 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.